Takeda Uses AcuraStem Deal To Bolster Neuro Pipeline, Move Into ALS

Takeda
Takeda will pursue ALS therapy under licensing pact with AcuraStem • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business